“The Center for Drug Evaluation and Research has seven robotic process automation projects in development as it works to free up staff for its core science mission.”
“An agency within the Food and Drug Administration, CDER ensures drugs on the market are safe and effective — regulating them throughout their lifecycle.”
“Many CDER employees have pharmaceutical science or medical degrees but find themselves performing repetitive, manual administrative tasks like arranging meetings…”
“The FDA is recognized in the RPA space for automating drug intake forms, as well as work within its chief financial officer’s office. But CDER has quietly put several RPA use cases into production enterprisewide…”
“Bots now ensure applications are complete before transcribing the information in them from PDFs into CDER’s system. Then the bots determine where to route new drug, investigation and master file submissions among hundreds of workflows so reviewers and project managers have their assignments…”
“CDER estimates the seven new RPA projects in development…” Read the full article here.
Source: RPA is helping with FDA’s drug evaluation and research – By Dave Nyczepir, September 20, 2019. FedScoop.
